OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Jill Wechsler is Pharmaceutical Technology's Washington Editor, email@example.com.
Biotech firms face new issues as FDA weighs policies to streamline generic-drug approvals and reduce patent disputes.